NCT03792841 2025-10-16Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPCAmgenPhase 1 Terminated212 enrolled
NCT05369000 2025-08-01Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate CancerLava TherapeuticsPhase 1 Terminated96 enrolled
NCT04032704 2025-03-10A Study of Ladiratuzumab Vedotin in Advanced Solid TumorsSeagen Inc.Phase 2 Terminated205 enrolled 54 charts
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled